Your browser doesn't support javascript.
loading
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy.
Asdourian, Maria S; Shah, Nishi; Jacoby, Ted V; Thompson, Leah L; Otto, Tracey; Semenov, Yevgeniy R; Reynolds, Kerry L; Chen, Steven T.
Afiliação
  • Asdourian MS; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Shah N; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Virginia Commonwealth University School of Medicine, Richmond, Virginia.
  • Jacoby TV; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; The University of Hawaii at Manoa John A. Burns School of Medicine, Honolulu, Hawaii.
  • Thompson LL; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Otto T; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
  • Semenov YR; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Reynolds KL; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Chen ST; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: stchen@partners.org.
J Am Acad Dermatol ; 88(1): 246-249, 2023 01.
Article em En | MEDLINE | ID: mdl-35577231

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article